Literature DB >> 11967343

Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage.

Regina Hofmann-Lehmann1, Josef Vlasak, Agnès-Laurence Chenine, Pei-Lin Li, Timothy W Baba, David C Montefiori, Harold M McClure, Daniel C Anderson, Ruth M Ruprecht.   

Abstract

Neonatal rhesus macaque 95-3 was inoculated with nonpassaged simian-human immunodeficiency virus strain SHIV-vpu(+), which encodes env of the laboratory-adapted human immunodeficiency virus (HIV) strain IIIB and is considered nonpathogenic. CD4(+) T-cell counts dropped to <200 cells/microl within 4.6 years, and monkey 95-3 died with opportunistic infections 5.9 years postinoculation. Transfer of blood from 95-3 to two naive adult macaques resulted in high peak viral loads and rapid, persistent T-cell depletion. Progeny virus evolved in 95-3 despite high SHIV-vpu(+) neutralizing antibody titers and still used CXCR4 but, in contrast to parental SHIV-vpu(+), productively infected macrophages and resisted neutralization. Sequence analysis revealed three new potential glycosylation sites in gp120; another two were lost. Strikingly similar mutations were detected in a laboratory worker who progressed to AIDS after accidental HIV-IIIB infection (T. Beaumont et al., J. Virol. 75:2246-2252, 2001), thus supporting the SHIV-vpu(+)/rhesus macaque system as a relevant model. Similar mutations were also described after rapid passage of chimeric viruses encoding IIIB env in rhesus and pig-tailed macaques (M. Cayabyab et al., J. Virol. 73:976-984, 1999; Z. Q. Liu et al., Virology 260:295-307, 1999; S. V. Narayan et al., Virology 256:54-63, 1999; R. Raghavan et al., Brain Pathol. 7:851-861, 1997; E. B. Stephens et al., Virology 231:313-321, 1997). Thus, HIV-IIIB env evolved similarly in three different species; this selection occurred in chronically infected individuals during disease progression as well as after rapid virus passage. We postulate that evolutionary pressure led to the outgrowth of more aggressive viral variants in all three species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967343      PMCID: PMC136137          DOI: 10.1128/jvi.76.10.5278-5284.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  A role for carbohydrates in immune evasion in AIDS.

Authors:  J N Reitter; R E Means; R C Desrosiers
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

2.  The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain.

Authors:  M Schreiber; C Wachsmuth; H Müller; S Odemuyiwa; H Schmitz; S Meyer; B Meyer; J Schneider-Mergener
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.

Authors:  J Cao; N Sullivan; E Desjardin; C Parolin; J Robinson; R Wyatt; J Sodroski
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques.

Authors:  R Raghavan; E B Stephens; S V Joag; I Adany; D M Pinson; Z Li; F Jia; M Sahni; C Wang; K Leung; L Foresman; O Narayan
Journal:  Brain Pathol       Date:  1997-07       Impact factor: 6.508

5.  Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing.

Authors:  R Shibata; F Maldarelli; C Siemon; T Matano; M Parta; G Miller; T Fredrickson; M A Martin
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.

Authors:  K A Reimann; A Watson; P J Dailey; W Lin; C I Lord; T D Steenbeke; R A Parker; M K Axthelm; G B Karlsson
Journal:  Virology       Date:  1999-03-30       Impact factor: 3.616

7.  Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS.

Authors:  Y Lu; C D Pauza; X Lu; D C Montefiori; C J Miller
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-09-01

8.  Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain.

Authors:  M J Papandreou; E Fenouillet
Journal:  Virology       Date:  1998-02-01       Impact factor: 3.616

9.  Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.

Authors:  A Li; H Katinger; M R Posner; L Cavacini; S Zolla-Pazner; M K Gorny; J Sodroski; T C Chou; T W Baba; R M Ruprecht
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).

Authors:  M Cayabyab; G B Karlsson; B A Etemad-Moghadam; W Hofmann; T Steenbeke; M Halloran; J W Fanton; M K Axthelm; N L Letvin; J G Sodroski
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  7 in total

1.  Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.

Authors:  Mauro Pistello; Donatella Matteucci; Simone Giannecchini; Francesca Bonci; Olimpia Sichi; Silvano Presciuttini; Mauro Bendinelli
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Molecular basis of adaptive convergence in experimental populations of RNA viruses.

Authors:  José M Cuevas; Santiago F Elena; Andrés Moya
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

3.  A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression.

Authors:  For Yue Tso; Federico G Hoffmann; Damien C Tully; Philippe Lemey; Robert A Rasmussen; Hong Zhang; Ruth M Ruprecht; Charles Wood
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

4.  Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection.

Authors:  Mila Ayash-Rashkovsky; Agnès-Laurence Chenine; Lisa N Steele; Sandra J Lee; Ruijiang Song; Helena Ong; Robert A Rasmussen; Regina Hofmann-Lehmann; James G Else; Peter Augostini; Harold M McClure; W Evan Secor; Ruth M Ruprecht
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

5.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 6.  Coreceptor use in nonhuman primate models of HIV infection.

Authors:  Silvana Tasca Sina; Wuze Ren; Cecilia Cheng-Mayer
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

7.  Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.

Authors:  For Yue Tso; Damien C Tully; Sandra Gonzalez; Christopher Quince; On Ho; Patricia Polacino; Ruth M Ruprecht; Shiu-Lok Hu; Charles Wood
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.